Heung Kim is the founder of Immuneoncia Therapeutics. Immuneoncia Therapeutics has raised $86M in total funding. Latest round: IPO.
Heung Kim serves as the CEO of Immuneoncia Therapeutics, a company specializing in immuno-oncology therapeutics. Immuneoncia Therapeutics, established in 2016, is a joint venture between Yuhan Corp. and Sorrento Therapeutics Inc. The company aims to develop immuno-oncology therapeutics to transform the standard of care in cancer treatment. Immuneoncia Therapeutics raised $24 million from its Kosdaq listing in May 2025.
Full founder directory · Investor directory · Company funding database · Fundraising library